Skip to main content
. 2017 Jul 6;5:2676. Originally published 2016 Nov 16. [Version 3] doi: 10.12688/f1000research.8231.3

Figure 1. Overview of distribution of survival and censoring times in training data from the ASCENT-2, VENICE, MAINSAIL, and ENTHUSE-33 trial 22– 25.

Figure 1.

Numbers in brackets denote the total number of patients in the respective trial, and the dashed line is the median follow-up time in the ENTHUSE-33 trial, which was used as independent test data.